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Abstract: Bovine anaplasmosis is a tick-borne disease with zoonotic potential, caused by the obligate
intracellular bacterium Anaplasma marginale. The disease is distributed worldwide in tropical and
subtropical regions. The economic losses from anaplasmosis in animals is of significant importance
because it causes severe morbidity and mortality in cattle. Recovered animals may become persistent
carriers. Epidemiological information on the actual status of bovine anaplasmosis in Egypt is scarce.
Thus, this study aimed to determine anti-Anaplasma antibody and DNA in serum samples using
ELISA and PCR, respectively. In total, 758 bovine sera were collected from cattle farms located
in 24 Egyptian governorates in 2015 to 2016. Sera were analyzed with the commercially available
‘Anaplasma antibody competitive ELISA v2’ kit and ‘AmpliTest Anaplasma/Ehrlichia spp. real time
TaqMan TM PCR. Anaplasma spp. antibodies were detected in 140 (18.5%) (CI: 15.8–21.4%) of the
investigated sera by ELISA, and Anaplasma/Ehrlichia-DNA was detected in 40 (5.3%) (CI: 3.8–7.1%)
of the positive sera by real time PCR. Co-detection of both Anaplasma spp. and Coxiella burnetii-specific
antibodies was proven in 30 (4%) of the investigated sera. The results of this work confirm the
significant prevalence of bovine anaplasmosis in Egypt. Raising awareness in decision makers of the
public health, veterinarians and animal owners is required to reduce the spread of infection.
Keywords: Anaplasma marginale; Bovine anaplasmosis; Coxiella burnetii; Egypt; prevalence; ELISA;
real time PCR
1. Introduction
Bovine anaplasmosis is caused by the obligate intracellular bacterium Anaplasma marginale,
(Alphaproteobacteria: Rickettsiales: Anaplasmataceae) that was first described by Sir Arnold Theiler
in 1910 as the causative agent of gall sickness in cattle [1]. Anaplasmosis is a tick-borne disease and
bacteria replicate within the epithelial cells of the tick midgut [2,3]. It is endemic in tropical and
subtropical areas worldwide. Anaplasmosis could be misdiagnosed with other tick-borne diseases
caused by Babesia (B.) bovis and B. bigemina, which have a similar geographical distribution and cause
anemia in cattle [4]. Besides transmission by ticks, these hemoprotozoa and A. marginale can also
be transmitted mechanically by biting flies [5], needles [6], ear-tagging, castration and dehorning
equipment [7,8], and parasites of migratory wild birds [9,10].
Other Anaplasma species that may cause bovine anaplasmosis are A. centrale causing only a
mild disease, and A. bovis and A. phagocytophilum known as bovine ehrlichiosis and tick-borne fever,
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respectively [11]. They can infect cattle and cause a reduction of milk production. Bovine congenital
transmission was reported for A. phagocytophilum [12], which has been recognized as a zoonotic
agent [8,13]. The severity of symptoms depends on several host factors such as its immune status and
possible coinfections by other pathogens [13]. Symptoms occur after a latency period i.e., progressive
anemia due to multiplication of A. marginale or A. centrale within mature erythrocytes. Other symptoms
are fever, inappetence, loss of coordination, breathlessness, reduced growth rate, abortions, and
stillbirth. Compared to other pathogenic bacteria, there is no report proving the transmission of
Anaplasma spp. to humans via animal products [14]. In humans, blood transfusion and organ
transplantation have been recognized as modes of transmission for A. phagocytophilum [15–17].
Anaplasma spp. in general have long life persistence and are able to remain in populations
for months or years, which has a significant influence on spreading and new outbreaks of
anaplasmosis [8,18,19]. Control measures should include regular monitoring, timely treatment
and countermeasures against the arthropod vectors [5], but the feasibility depends on various factors
such as geographic location and implementation costs of regulatory measures e.g., use of vaccines
or antibiotics [20]. Variations of vector competence and limitations of our knowledge on the tick
immune responses hinder control efforts and especially our understanding of the arthropod–microbe
interaction [21]. Despite the limited current knowledge, a tick vaccine is already under development [22].
Bovine anaplasmosis is an economically important disease that causes losses in the dairy and beef
industries through reduced milk production, weight loss, abortion, icterus, and even death in some
cases [23,24]. There exists no reports on the antibiotic resistance of these pathogens. Tetracyclines
and imidocarb are recommended by the World Organisation for Animal Health (OIE) to reduce
probable side effects of an attenuated A. centrale live vaccine [6]. Marcondes reported on successful
oxytetracycline treatment [25].
The NCBI database holds only two complete whole genome sequences of A. marginale and four
of A. phagocytophilum isolates. Diagnostic assays used in veterinary medicine to identify A. marginale
and A. centrale showed that the competitive ELISA (cELISA) test is recommend for monitoring and
screening of populations while PCR and Giemsa are recommended for staining for the examination of
clinical cases [6].
The average number of cattle kept per year in Egypt between 2002 and 2014 was more than 4.6
million, highlighting the importance of dairy and meat production in this country. Bovine anaplasmosis
in Egypt was mentioned first in the national report of 1966 [26]. Since then, the disease was detected in
many governorates. In Egypt, several studies reported anaplasmosis caused by A. marginale in cattle,
water buffaloes and camel [27–32]. Frequently used techniques in these reports were microscopy [30],
competitive ELISA (cELISA) [33,34], immunofluorescent assay (IFA) [35,36], or molecular assays i.e.,
conventional PCR [27] or real-time PCR [37].
Epidemiological studies are useful for the monitoring and control of diseases, and subsequently,
the reduction of costs. For bovine anaplasmosis, such studies were limited to some governorates, and
a comprehensive study for the whole of Egypt is missing. The objective of this study was to update the
epidemiological information about bovine anaplasmosis in Egypt through investigating the prevalence
of anaplasmosis in cattle within 27 Egyptian governorates using cELISA and real time PCR, to predict
risk factors and provide baseline data for an effective design of disease control.
2. Materials and Methods
2.1. Study Area and Sample Information
Egypt is a vast desert plateau interrupted by the Nile valley and Delta region. Approximately
95% of the human population lives within 20 km of the Nile River and its delta. This territory is
divided into 27 governorates, which have been categorized into three large domains: the Western
part, the Eastern part and the Nile Valley and Delta region. In total, 758 cattle serum samples were
collected during a Q fever prevalence study between October 2015 and March 2016 from 61 different
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farms located in 61 districts (sample sites) of 24 governorates (North Sinai, South Sinai and Luxor were
excluded). A questionnaire that contained information about the animals, such as age, husbandry
systems, infesting parasites, contact with other animals (i.e., dogs, etc.), and GPS data was used in
this work (Figure 1). Age was categorized in two groups: ≤4 or >4 years. Three different husbandry
systems were present: stable/stationary, pasture and nomadic.
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(-) No samples were available. 
2.2. Detection of Anaplasma spp.-Specific Antibodies Using cELISA 
Sera were stored at −20°C and tested for specific antibodies against Anaplasma spp. using a 
competitive ELISA (cELISA) (Veterinary Medical Research and Development Inc., Pullman, WA, USA) 
according to the manufacturer’s instructions. The assay has a sensitivity of 100% and specificity of 99.7% 
according to the supplier [38]. All sera were tested in duplicate. Results were calculated according to 
manufacturer’s recommendation: percentage inhibition (% I) = 100 (1 − [sample OD620/OD620 of 
negative control]). Samples with a value ≥ 30% were considered as positive.  
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The DNA was extracted and purified from all seropositive and suspected positive samples with 
only one positive cELISA result using High Pure PCR Template Preparation Kit (Roche, Mannheim, 
Figure 1. Sampling sites in Egypt. The map illustrates the position of sampling sites in each governorate.
The distribution of 758 cattle sera (Figure 1) was 283 (37.33%) from the Nile Delta domain,
337 (44.06%) from the Western domain, and 138 (18.2%) from the Eastern domain. Out of the 758
investigated cattle, 414 (54.61%) were kept in stables/stationary and 310 (40.89%) were nomadic. Tick
infestation was recorded in 55.8% (n = 423), and 60.16% of animals were older than 4 years. All data
regarding age group, animal housing and others are summarized in Table 1.
Table 1. Number of animals sampled per domain with age group, husbandry system and tick infestation.
Domain WesternDomain Nile Delta
Eastern
Domain Total
Cattle 334 (44.06%) 283 (37.33%) 135 (18.2%) 758
Animal age ≤ 175 (57.94%) 73 (24.17%) 54 (17.8 %) 302 (39.84%)
>4 years 162 (35.52%) 210 (46.05%) 84 (18.42%) 456 (60.16%)
Animal
husbandry
Stable/Stationary No samples 280 (67.63%) 134 (32.36%) 414 (54.61%)
Nomadic 303 (97.7 %) 3 (0.96%) 4 (1.29% 310 (40.89%)
Nomadic & Pasture 34 (-) (-) 34 (4.48%)
Tick infestation 193 (45.62%) 149 (36.69%) 81 (19.14%) 423 (55.8%)
Cattle kept in spatial separate (-) 280 (68.96%) 126 (31.03%) 406 (53.56%)
Others animal species living on farm 8 (32%) 15 (60%) 2 (8%) 25 (3.29%)
(-) No samples were available.
2.2. Detection of Anaplasma spp.-Specific Antibodies Using cELISA
Sera were stored at −20 ◦C and tested for specific antibodies against Anaplasma spp. using a
competitive ELISA (cELISA) (Veterinary Medical Research and Development Inc., Pullman, WA, USA)
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according to the manufacturer’s instructions. The assay has a sensitivity of 100% and specificity of 99.7%
according to the supplier [38]. All sera were tested in duplicate. Results were calculated according
to manufacturer’s recommendation: percentage inhibition (% I) = 100 (1 − [sample OD620/OD620 of
negative control]). Samples with a value ≥ 30% were considered as positive.
2.3. Detection of Anaplasma spp./Ehrlichia spp. DNA Using Real Time PCR
The DNA was extracted and purified from all seropositive and suspected positive samples with only
one positive cELISA result using High Pure PCR Template Preparation Kit (Roche, Mannheim, Germany)
according to the manufacturer’s instructions. The concentration and quality of DNA was measured
using a NanoDrop1000® (Thermo Fisher, Wilmington, NC, USA) according to the manufacturer’s
guidelines. The mean DNA concentration was 11.31 ± 6.9 ng/µL. DNA samples were stored at −20 ◦C
until further use. For detection of Anaplasma spp./Ehrlichia spp.-specific DNA, the AmpliTest Anaplasma
spp./Ehrlichia spp. Kit (Amplicon Ltd., Wrocław, Poland) was used according to the manufacturers
guidelines. The assay has a sensitivity and specificity of 100% according to the manufacturer.
The presence of Anaplasma spp. Ehrlichia spp.-specific DNA was determined in duplicates. A Ct
value ≤ 38 was considered as positive and values between 38 and 40 were considered as uncertain
results as recommended by the supplier. Species identification was performed on qPCR positive
and questionable samples using conventional PCR targeting the 16S rRNA gene and sequencing as
described elsewhere [39].
2.4. Statistical Analysis
Data analysis were performed with SPSS Statistics software® (IBM Corp, Armonk, NY, USA,
version 19). Seroprevalence is the proportion of positive results measured in serum within a population.
Confidence interval (CI) was computed from binominal distribution of the obtained data (positivity
in population). Odds ratios (ORs) were calculated using a relative risk option. In the present survey,
possible risk factors such as age, tick infestation, animal husbandry system, age group (≤4 and >4 years),
and keeping condition (stable/stationary, nomadic and posture) were analyzed. The Chi-square test
was used to determine the association among categorized risk groups [40]. The multivariable regression
model was used to evaluate the effect of multiple variables in the same model using ANOVA and F
test for cELISA and real time PCR results.
2.5. Ethical Statement
This study was carried out in strict accordance with the recommendations of the Egyptian Network
of Research Ethics Committees (ENREC), which complies with the international laws and regulations
regarding ethical considerations in research. The ENREC approved this research work. For purposes
of this study, all animal owners consented to sampling.
3. Results
Out of 758 tested serum samples, 140 were seropositive by cELISA, and the overall estimated
seroprevalence of anaplasmosis was 18.5% (CI: 15.8–21.4%). In 61 investigated farms, 31 (50.8%) farms
had seropositive cattle for anaplasmosis (Table 2). The results of seroprevalence for each governorates
are shown in Table 2. The majority of seropositive animals were located in Gharbia (100%), Suez (83.3%)
and Port Said (33.3%), while the lowest prevalence was recorded in Sohag (4.7%) and Aswan (5.2%).
Anaplasma/Ehrlichia-specific DNA was detected in 5.3% (CI: 3.8–7.1%) of the seropositive samples
by real time PCR. Species differentiation was attempted by 16S rRNA amplification and sequencing.
Only four of all qPCR positive and questionable samples were positive for the 16S rRNA gene and
showed 100% sequence identity with A. marginale (data not shown). Most of the PCR-positive animals
were from the Nile Valley and Delta region (7.1%). Only 3.95% (30/758) of sera were serologically
positive for Coxiella burnetii and Anaplasma spp. (Table 2).
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Table 2. Prevalence of bovine anaplasmosis in 24 investigated governorates.








Matrouh 167 4 (4) 25 (15) 7 (4.2) 3
New valley 170 6 (5) 36 (21.6) 9 (5.3) 8




Alexandria 9 3 (1) 1 (11.1) 0 0
Assiut 33 2 (2) 10 (30.3) 2 (6.1) 2
Aswan 58 3 (1) 3 (5.2) 2 (3.4) 2
Cairo 12 2 (1) 2 (16.7) 0 0
Dakahlia 11 2 (1) 2 (18.2) 1 (9.1) 0
Damietta 12 2 (2) 3 (25) 3 (25) 0
Fayoum 9 3 (2) 2 (22.2) 0 0
Gharbia 2 1 (1) 2 (100) 2 (100) 0
Ismailia 7 4 (2) 2 (28.5) 0 0
Minya 12 2 (1) 1 (8.3) 1 (8.3) 0
Port Said 12 2 (2) 4 (33.3) 3 (25) 0
Qena 22 3 (2) 11 (50) 3 (13.6) 0
Sohag 21 2 (1) 1 (4.8) 0 1
Suez 12 2 (2) 10 (83.3) 3 (25) 4
Beheira 1 1 (0) 0 0 0
Beni-Suef 22 2 (0) 0 0 0
Giza 9 3 (0) 0 0 0
Kafr El Sheikh 7 3 (0) 0 0 0
Menoufia 9 3 (0) 0 0 0
Qualyubia 1 1 (0) 0 0 0
Sharkia 2 1 (0) 0 0 0
Total 758 61 (33%) 140 (18.5%) 40 (5.3%) 30 (4%)
The number of positive samples per domain ranged between 18.1–19.08% and 2.9–7.1%,
respectively (Table 3).
Sixty percent of cELISA-positive animals were older than 4 years, with 56.42% of those animals
kept in stables/stationary and 36.42% being nomadic. Sixty-five percent of positive animals were
infested with ticks (Table 3). Tick infestation was the only risk factor that had a significant association
with bovine anaplasmosis (χ2 = 9.36, p = 0.009), which is reflected by an Odds ratio of 1.7. Detailed
information about this risk factor analyses is displayed in Table 3. The multivariable regression model
demonstrated no relationship between risk factors of anaplasmosis (cELISA < ANOVA; F (6,744) =
0.799, p = 0.571> / real time PCR < ANOVA; F (6,744) = 2.005, p = 0.063>).
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Table 3. Potential risk-associated factors for bovine anaplasmosis in Egypt.
c ELISA Real Time PCR
Risk Factor



































Domain 61 (22) 43.57% (55%)
61/337 = 18.10%
(6.52%) 18.10% 1.09 14.1–22.6%
χ2(4) = 2.23;
p = 0.69
16 (9) 4.74% 2.7–7.6%
χ2(6) = 9.01; p
= 0.17
Nile Delta 54 (11) 38.57%(27.5%)
54/283 = 19.08%
(3.88%) 19.08% 0.92 14.7–24.2% 20 (1) 7.1% 4.4–10.7%
Eastern
Domain 25 (7) 17.85 (17.5%)
25/138 = 18.11%
(5.07%) 18.11% 0.99 12.1–25.6% 4 (3) 2.9% 0.8–7.3%
Total 140 (40) 140/758 =18.46% (5.27%) 18.5% ND 15.8–21.4% 40 (13) 5.3% 3.8–7.1%
Animal
age group
≤4 years 56 (17) 40% (42.5%) 18.54% (5.62%) 18.54% 1.02 14.3–23.4% χ2(2) = 0.144;
p = 0.93
19 (7) 6.3% 3.8–9.7% χ2(3) = 2.57; p
= 0.46>4 years 84 (23) 60% (57.5%) 18.42% (5.04%) 18.42% 0.98 15.0–22.3% 21 (6) 4.60% 2.9–7%
Animal
husbandry
Stable/Stationary 79 (18) 56.42% (45%) 19.08% (4.34%) 19.1% 0.96 15.4–23.2%
χ2(6) = 8.30;
p = 0.21
24 (4) 5.8% 3.7–8.5%
χ2(9) = 8.82; p
= 0.69
Nomadic 51 (22) 36.42% (55%) 16.45% (7.09%) 16.5% 0.98 12.5–21.1% 13 (8) 4.2% 2.3–7.1%
Nomadic &
Pasture 10 7.14% 29.41% 29.41% 1.34 15.1–47.5% 3 (1) 8.8% 1.9–23.7%
Tick infestation 91 (27) 65% (67.5%) 21.51% (6.38%) 19.45% 1.71 17.7–25.7% χ
2(2) = 9.36;
p = 0.009a
26 (11) 6.1% 4.1–8.9% χ
2(3) = 11.74;
p = 0.45
Animals kept separate 79 (18) 56.42% (45%) 19.45% (4.43%) 19.5% 1.02 15.7–23.6% χ
2(2) = 1.64;
p = 0.44
24 (4) 5.9% 3.8–8.7% χ
2(4) = 3.38; p
= 0.33
Another animal species living
on farm 6 (1) 25% (4%) 24% (4%) 24% ND 9.4–45.1% ND 1 (2) 4% 0.1–20.4% ND
Chi-square analysis calculated by ignoring the missing samples to avoid a high percentage of expected frequency below 5.a Demonstrated significant association for tick infestation. Both
assays were conducted in duplicate. ‘suspicious’ means that samples have only one positive result.
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4. Discussion
The aim of this study was to assess the prevalence of bovine anaplasmosis in Egypt to predict
risk factors and provide baseline data for an effective design of disease control. Anaplasmosis has
been recorded in cattle in Egypt for more than 50 years since it was first mentioned in 1966 [26], and
was present in at least 22 of 27 governorates and the majority of positive samples reported from
Suez, Dakahilia, Sharkir, Kafar el-Sheikh, Garbia, Manofia, and Minya [26]. Despite the evidence for
endemicity of Anaplasma spp. in Egypt in official reports, a lack of data in the scientific literature is
obvious. Only seven articles were found that provide data on anaplasmosis in cattle and one each in
water buffaloes and camels. It is possible that the infections are more prevalent as reported, due to
misdiagnosis and undetected carrier animals. It is not obvious why anaplasmosis does not get the
expected attention from non-governmental scientists. This shows a strong need for more detailed
information on the distribution of anaplasmosis in Egypt.
To understand the epidemiology of bovine anaplasmosis in Egypt, screening of sera collected for
a previous Q fever survey were used to determine prevalence, risk factors and distribution of bovine
anaplasmosis in Egypt.
In this study, the seroprevalence of anaplasmosis in Qena governorate was 50%, which is higher
than that reported previously by Fereig et al. (28%) using a cELISA test [33]. Molecular investigation
done by El-Ashkar et al. (2015) showed a high difference for the presence of A. marginale-specific
DNA in sera when compared to the obtained data in this study, 20.12% vs 9.09%, respectively [27].
These discrepancies may be caused by different sampling times, sampling strategies and locations.
It has to be noted that the samples in this study were taken on an independent, statistically-based
sampling plan in contrast to sampling during locally limited outbreaks or samples taken from clinical
practice. Most reports on bovine anaplasmosis were from animals, which were clinically ill or had
a history of anaplasmosis. Screening by IFA was performed twice previously [35,36]. This test
has several drawbacks i.e., limitations on the number of tests per day to be done by one operator
and nonspecific fluorescence [6]. Hence, it is not recommended by OIE [6]. Studies using IFA for
diagnosis of anaplasmosis cannot be compared to other studies using different OIE suitable assays
i.e., cELISA. Six studies have used microscopic examination to confirm the agents near the margin
of the erythrocyte. This method is recommended by the OIE for the confirmation of clinical cases of
anaplasmosis. However, microscopy is not appropriate for prevalence studies and does not allow
species differentiation [6]. The combination of cELISA and real time PCR proved to be easy in
implementation in the laboratory and allows high throughput analysis of samples.
Chi square analyses resulted in a significant association for tick infestation with χ(2) = 9.36 and
p = 0.009. This finding was expected, as ticks are vectors of anaplasmosis. There is no significant
association between anaplasmosis and Q fever (χ(6) = 6.27, p = 0.18). In addition, the multivariable
regression model indicated no dependency between risk factors and their relevance for anaplasmosis
(cELISA < ANOVA; F (6,744) = 0.799, p = 0.571> / real time PCR < ANOVA; F (6,744) = 2.005, p = 0.063>).
Summarized data from Egyptian literature [27,33,34,36], official reports, and this work show that
bovine anaplasmosis is present in the governorates Matrouh, Damietta, Dakahila, and Qena (except
Qalybia due to in-availability of samples). An inconsistency of national reports and our results for
Sharkia and Beheira are based on limited availability of samples. No official reports from Aswan and
Red sea were available, but in the presented study, 5.17% and 18.51% were positive by cELISA, and
thereof, 3.44% and 2.89% were PCR-positive for Anaplasma spp./Ehlichia spp.-specific DNA, respectively.
Species differentiation using conventional PCR targeting the 16S rRNA gene was not successful.
Only four samples yielded PCR products with 100% sequence identity to A. marginale. This might be
due to a higher sensitivity of the qPCR assay compared to conventional PCR and a low amount and
quality of DNA. Beni-Suef is the only governorate in which no outbreaks have been reported and was
also found to have no positive samples in this study. Bovine anaplasmosis is present in neighboring
governorates, but why it is absent from this governorate is unknown. We found antibodies specific
for bovine anaplasmosis in 17 governorates, which coincides well with official statistics. The country
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has an enormous burden of diseases and outbreaks; effective control of bovine anaplasmosis should
include control of the tick vectors. In all domains, cattle were infested with ticks, which may be due to
the unavailability of acaricides or access to information affecting the ability of animal owners to control
ticks. This might also indicate that there is not sufficient veterinary care. Tick vaccines have a negative
influence on tick feeding and reproduction [22] but are not available for field use yet. Anaplasma
centrale live vaccines can give partial protection against bovine anaplasmosis and might be useful
in future control programs. The role of nomadic husbandry in the dissemination of anaplasmosis
is unknown and is still not investigated yet. The spread of diseases through human behavior [41],
humans activities [42], and human mobility [43] are well known. The movement of carrier animals that
do not display any obvious symptoms of anaplasmosis may be an additional factor to be considered.
5. Conclusions
National reports show that bovine anaplasmosis is widely distributed in Egypt. The results of
this study confirm the nationwide and significant prevalence of bovine anaplasmosis. In order to
reduce the spread of infection, more attention to control measures is required. Raising of awareness in
decision makers of the public health and private sectors, especially veterinarians and animal owners,
is an effective but simple way to improve the situation of anaplasmosis in a reasonably short time.
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